Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true?

Academic Article
Publication Date:
2022
Short description:
Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true? / Guidotti, L.G., La Vecchia, C., Colombo, M.. - In: HEPATOLOGY. - ISSN 1527-3350. - 76:2(2022), pp. 300-302. [Epub ahead of print] [10.1002/hep.32445]
Iris type:
1.1 Articolo in rivista
Keywords:
Aspirin; Hepatitis B virus; Humans; Liver Cirrhosis; Risk Factors; Carcinoma, Hepatocellular; Liver Neoplasms
List of contributors:
Authors of the University:
Handle:
https://iris.unisr.it/handle/20.500.11768/133837
Published in:
HEPATOLOGY
Journal